Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Bellerophon Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Bellerophon Therapeutics Inc market cap is $146,800.00.
What is the 52-week high for Bellerophon Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bellerophon Therapeutics Inc 52 week high is $0.10 as of October 03, 2025.
What is the 52-week low for Bellerophon Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bellerophon Therapeutics Inc 52 week low is $0.01 as of October 03, 2025.
What was Bellerophon Therapeutics Inc stock price yesterday?
Bellerophon Therapeutics Inc stock price yesterday was $0.012.
What is the PE ratio of Bellerophon Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bellerophon Therapeutics Inc’s P/E ratio is -0.01.
What is the Price-to-Book ratio of Bellerophon Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Bellerophon Therapeutics Inc P/B ratio is 0.0394.
What is the 50-day moving average of Bellerophon Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Bellerophon Therapeutics Inc 50-day moving average is $0.0354.